CN Patent

CN106939011B — 一种奈他地尔关键中间体的制备方法

Assigned to Jiangsu ailikang Pharmaceutical Technology Co.,Ltd. · Expires 2019-11-08 · 7y expired

What this patent protects

本发明提供了一种奈他地尔关键中间体的制备方法，以卤代苄醇为起始原料，依次经过苄醇基保护、与丙二酸酯催化偶联、氨解、还原、氨基保护和水解制备。原料价廉易得，反应条件温和，反应可控性高，具有良好的工业化应用前景。

USPTO Abstract

本发明提供了一种奈他地尔关键中间体的制备方法，以卤代苄醇为起始原料，依次经过苄醇基保护、与丙二酸酯催化偶联、氨解、还原、氨基保护和水解制备。原料价廉易得，反应条件温和，反应可控性高，具有良好的工业化应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN106939011B
Jurisdiction
CN
Classification
—
Expires
2019-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu ailikang Pharmaceutical Technology Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.